MENU
MIRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mirum Pharmaceuticals (MIRM) Earnings Date & Reports
Mirum Pharmaceuticals Inc... Show more
A.I. Advisor
published Earnings
MIRM is expected to report earnings to fall 94.38% to -75 cents per share on July 30
Q2'26
Est.
$-0.76
Q1'26
Missed
by $13.09
Q4'25
Missed
by $0.08
Q3'25
Beat
by $0.20
Q2'25
Beat
by $0.21
The last earnings report on May 06 showed earnings per share of -1343 cents, missing the estimate of -34 cents. With 224.65K shares outstanding, the current market capitalization sits at 7.50B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Industry Biotechnology
Profile
Details
Industry
N/A
Address
989 East Hillsdale Boulevard
Phone
+1 650 667-4085
Employees
372
Web
https://www.mirumpharma.com